Duality Advisers’s ResMed RMD Stock Holding History

Duality Advisers’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,275	Closed	-$1.96M	–	728
2023 Q3	$1.96M	Sell	13,275 -6,047	-31%	-$1.09M	0.24%	163
2023 Q2	$4.22M	Buy	+19,322	New	+$4.31M	0.53%	28
2023 Q1	–	Sell	-25,775	Closed	-$5.36M	–	735
2022 Q4	$5.36M	Buy	+25,775	New	+$5.66M	0.61%	4
2022 Q2	–	Sell	-4,234	Closed	-$1.03M	–	824
2022 Q1	$1.03M	Sell	4,234 -20,812	-83%	-$5.03M	0.11%	312
2021 Q4	$6.52M	Buy	25,046 +3,836	+18%	+$995K	0.71%	17
2021 Q3	$5.59M	Buy	+21,210	New	+$5.8M	0.43%	58
2021 Q2	–	Sell	-26,827	Closed	-$5.21M	–	710
2021 Q1	$5.21M	Buy	26,827 +17,070	+175%	+$3.42M	0.45%	50
2020 Q4	$2.07M	Sell	9,757 -17,563	-64%	-$3.5M	0.15%	206
2020 Q3	$4.68M	Buy	+27,320	New	+$5.05M	0.3%	66
2019 Q4	–	Sell	-19,470	Closed	-$2.63M	–	430
2019 Q3	$2.63M	Sell	19,470 -7,680	-28%	-$1.01M	0.15%	183
2019 Q2	$3.31M	Buy	+27,150	New	+$3.01M	0.29%	104

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Duality Advisers's RMD Position: Q4 2023 in Review

Duality Advisers sold out of ResMed (RMD) in Q4 2023, closing a stake of 13,275 shares — an estimated $1.96M sold.

Duality Advisers first reported a position in RMD in Q2 2019 and held it in 11 quarters. The position peaked at $6.52M in Q4 2021. 688 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

Duality Advisers reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
Duality Advisers sold 13,275 ResMed shares in Q4 2023, an estimated $1.96M.
Duality Advisers first reported a position in ResMed in Q2 2019 and held it in 11 quarters.
Duality Advisers's ResMed position peaked at $6.52M in Q4 2021.
688 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on Duality Advisers's 13F filing for Q4 2023, filed 1 Feb 2024.